Januvia 25 MG tablet 90S
Ended Awarded
- Contract number
- SPE2DB26FJRWV
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,345
Award facts
- Contract value 100% obligated
- $2,344.68 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $2,344.68 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Januvia 25 mg tablets (90-count packages). The award was issued on October 28, 2025, with an ultimate completion date of October 29, 2025, and carries no set-aside designation, indicating the company competed in unrestricted federal procurement. DMS Pharmaceutical Group is registered as a prime vendor under the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to ensure reliable pharmaceutical supply chains for Department of Defense healthcare operations worldwide.
This delivery order represents a routine pharmaceutical supply requirement under DMS Pharmaceutical Group's indefinite delivery contract (SPE2DR) with the Defense Logistics Agency, which was awarded on November 13, 2025, with a ceiling value of $499,999,999 and a completion date of December 31, 2036. The vendor's established performance across numerous delivery orders demonstrates its capability to fulfill diverse pharmaceutical requirements across multiple therapeutic categories, including branded and generic prescription medications, biologics, vaccines, and medical consumables. As one of multiple regional prime vendor contractors under PPV-G GEN V, DMS Pharmaceutical Group serves as a critical supplier supporting recurring medical supply needs of military healthcare facilities globally.
Quick answers
Who was awarded contract SPE2DB26FJRWV?
SPE2DB26FJRWV was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 28, 2025.
How much is contract SPE2DB26FJRWV worth?
The government has obligated $2,345 on SPE2DB26FJRWV.
Is contract SPE2DB26FJRWV an order under another contract?
Yes. SPE2DB26FJRWV is a delivery order under SPE2DB24D9803, an indefinite delivery contract.
Was contract SPE2DB26FJRWV competed?
The extent of competition for SPE2DB26FJRWV was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award